Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disorders.
Kwon M, Bailén R, Balsalobre P, Jurado M, Bermudez A, Badiola J, Esquirol A, Miralles P, López-Fernández E, Sanz J, Yañez L, Colorado M, Piñana JL, Dorado N, Solán L, Martínez Laperche C, Buño I, Anguita J, Serrano D, Díez-Martin JL; Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH). Kwon M, et al. Among authors: solan l. AIDS. 2019 Jul 15;33(9):1441-1447. doi: 10.1097/QAD.0000000000002209. AIDS. 2019. PMID: 30932952 Free article.
Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation.
Kwon M, Bailén R, Pascual-Cascón MJ, Gallardo-Morillo AI, García Sola A, Balsalobre P, Solán L, Dorado N, Muñoz C, Serrano D, Martínez-Laperche C, Buño I, Anguita J, Díez-Martin JL. Kwon M, et al. Among authors: solan l. Blood Adv. 2019 Nov 12;3(21):3351-3359. doi: 10.1182/bloodadvances.2019000236. Blood Adv. 2019. PMID: 31698447 Free PMC article.
Elafin as a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide.
Solán L, Carbonell D, Muñiz P, Dorado N, Landete E, Chicano-Lavilla M, Anguita J, Gayoso J, Kwon M, Díez-Martín JL, Martínez-Laperche C, Buño I. Solán L, et al. Front Immunol. 2021 Feb 19;12:516078. doi: 10.3389/fimmu.2021.516078. eCollection 2021. Front Immunol. 2021. PMID: 33679728 Free PMC article.
Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant.
Bailén R, Vicario JL, Solán L, Sánchez-Vadillo I, Herrera P, Calbacho M, Alenda R, López-Lorenzo JL, Humala K, Chinea A, Sánchez-Pina J, Balas A, Moreno MÁ, Arzuaga J, Pradillo V, Dorado N, Oarbeascoa G, Anguita J, Díez-Martín JL, Kwon M. Bailén R, et al. Among authors: solan l. Front Immunol. 2021 May 19;12:674658. doi: 10.3389/fimmu.2021.674658. eCollection 2021. Front Immunol. 2021. PMID: 34093576 Free PMC article.
Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms.
Vallejo M, Muñiz P, Kwon M, Solán L, Bailén R, Carbonell D, Chicano M, Suárez-González J, Catalán P, Bellón JM, Triviño JC, Dorado N, Gallardo D, Díez-Martín JL, Ramírez N, Martínez-Laperche C, Buño I. Vallejo M, et al. Among authors: solan l. Ann Hematol. 2022 Jul;101(7):1567-1576. doi: 10.1007/s00277-022-04841-8. Epub 2022 May 7. Ann Hematol. 2022. PMID: 35525883 Free PMC article.
Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy.
Bailén R, Alenda R, Herruzo-Delgado B, Acosta-Fleitas C, Vallés A, Esquirol A, Fonseca M, Solán L, Sánchez-Vadillo I, Bautista G, Bento L, López-Godino O, Pérez-Martínez A, Torrent A, Zanabili J, Calbacho M, Moreno MÁ, Pascual-Cascón MJ, Guerra-Domínguez L, Chinea A, García-Cadenas I, López-Corral L, Boix-Giner F, López Lorenzo JL, Humala K, Duarte R, Sampol A, Heras I, Vicario JL, Balas A, Oarbeascoa G, Fernández-Caldas P, Anguita J, Kwon M. Bailén R, et al. Among authors: solan l. Front Immunol. 2023 May 26;14:1165759. doi: 10.3389/fimmu.2023.1165759. eCollection 2023. Front Immunol. 2023. PMID: 37304258 Free PMC article.
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia.
González-López TJ, Pascual C, Álvarez-Román MT, Fernández-Fuertes F, Sánchez-González B, Caparrós I, Jarque I, Mingot-Castellano ME, Hernández-Rivas JA, Martín-Salces M, Solán L, Beneit P, Jiménez R, Bernat S, Andrade MM, Cortés M, Cortti MJ, Pérez-Crespo S, Gómez-Núñez M, Olivera PE, Pérez-Rus G, Martínez-Robles V, Alonso R, Fernández-Rodríguez A, Arratibel MC, Perera M, Fernández-Miñano C, Fuertes-Palacio MA, Vázquez-Paganini JA, Gutierrez-Jomarrón I, Valcarce I, de Cabo E, Sainz A, Fisac R, Aguilar C, Paz Martínez-Badas M, Peñarrubia MJ, Calbacho M, de Cos C, González-Silva M, Coria E, Alonso A, Casaus A, Luaña A, Galán P, Fernández-Canal C, Garcia-Frade J, González-Porras JR. González-López TJ, et al. Among authors: solan l. Am J Hematol. 2015 Mar;90(3):E40-3. doi: 10.1002/ajh.23900. Epub 2015 Jan 16. Am J Hematol. 2015. PMID: 25400215 Free article.
Seemingly trivial lesion with devastating consequences.
Suárez M EU, Villalba-Cuesta P, Arquero T, Llamas P, Solán L. Suárez M EU, et al. Among authors: solan l. EJHaem. 2022 Sep 27;3(4):1452-1454. doi: 10.1002/jha2.581. eCollection 2022 Nov. EJHaem. 2022. PMID: 36467822 Free PMC article. No abstract available.
49 results